Summary

Acne Medication market to surpass USD 14.68 billion by 2030 from USD 8.6 billion in 2020 at a CAGR of 5.49% in the coming years, i.e., 2021-30.

Product Overview
Acne vulgaris, often known as acne, is a common skin condition that occurs when the hair follicles get clogged as a result of excessive oil production, debris, and dead skin cells. Pimples, whiteheads, blackheads, and scars may accompany it. Inflammatory and non-inflammatory acne are the two forms of acne that exist. Acne therapy involves utilizing drugs and medications to remove dead skin cells, reduce sebum output, and eliminate germs.

Market Highlights
Acne Medication market is expected to project a notable CAGR of 5.49% in 2030
Acne medication market expansion is being fueled by an increase in the global occurrence of acne diseases. Teenagers' adoption of unhealthy lifestyles and growing acceptance of skincare products are two major reasons driving market growth. The availability and emergence of a wide range of products containing antibiotic agents, such as lotions, creams, and gels, as well as the additional advantages associated with their usage, would boost demand for acne medication.



Recent highlights in the Acne Medication Market
In April 2021, Acelity, In South Korea, Galderma announced the launch of Aklief, an acne treatment medication. This medication targets the retinoid receptor gamma in the retinoic acid receptor (RAR) in the skin, making acne therapy more efficient and effective. This strategic decision will help the corporation grow its operations in South Korea.

In January 2021, Eligo Bioscience and GlaxoSmithKline have formed a research collaboration. Eligobiotics' acne vulgaris therapy uses cutting-edge CRISPR-based therapeutic technology. This strategic partnership is anticipated to speed up research and development operations, giving the firm a competitive advantage.



Acne Medication Market: Segments
segment to grow with the highest CAGR during 2020-30
Acne Medication market is segmented by Formulation into Topical and Oral. Among these, the Topical category is expected to hold the highest CAGR in the forecast period. This is because retinoids, BPO, azelaic acid, antibiotics, and salicylic acid are used topically for acne maintenance and mild to severe acne.

Retinoids segment to grow with the highest CAGR during 2020-30
Acne Medication market is segmented by Product into Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid, and Others. Among these, the Retinoids category had the highest revenue share of more than 27% in 2020. The microcomedo–precursor lesion of acne is where the focus of topical retinoids is on. Based on the severity of acne, retinoids are typically used as a first-line treatment, either alone or in combination with other medications. They're commonly used to treat severe inflammatory acne, and they're also a popular choice for maintenance therapy. Retinoids also decrease microcomedones and follicular obstruction in both non-inflammatory and inflammatory acne. As a result of their higher efficacy and compatibility when coupled with other medicines, retinoids are expected to propel the market forward throughout the projected period.

Market Dynamics
Drivers
Growing awareness regarding the treatment options and advancements
The industry will grow in the coming years due to rising awareness of therapeutics in acne treatment and the increasing incidence of acne disorders in the many regions due to climate change. However, as a result of continuous advancements, increased knowledge of acne medication choices such as dermo-cosmetics, biologics, and complementary and alternative medicines (CAM) has boosted product acceptance across the globe. Several CAM therapies have been marketed as acne treatments as a result of research and development activities, and are generally considered safe.

Increasing disposable income of consumers
Because of the rising demand and adoption rate of acne medicine, a rise in consumer disposable income is expected to enhance the market for acne medication. Acne treatments are used to treat acne that is mild to severe and can result in deformity. Acne is a skin disease that affects the oil glands on certain skin surfaces. Growing public concern about their physical appearance is expected to fuel the expansion of the acne medicine industry. The expansion of the acne medicine market is being driven by rising instances of acne as a result of modern patients' lifestyles and its high prevalence among teenagers.

Restraint
Increased risk of side effects and blood clots
Topical acne medicines cause skin dryness, whereas oral acne medications cause dizziness and lightheadedness, as well as increasing the risk of blood clots in people with high blood pressure. The presence of alternative treatments such as laser therapy is also expected to restrain market expansion.

Acne Medication Market: Key Players
Allergan Plc

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Glaxosmithkline Plc
Johnson Johnson
Mayne Pharma Group Limited
Mylan N V
Nestle S A
Pfizer Inc
Sun Pharma
Teva Pharmaceutical Industry Ltd
Valeant Pharmaceutical International


Acne Medication Market: Regions
Acne Medication market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Acne Medication market in North America held the largest market share in the year 2019 as a result of significant advancements in acne treatment. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period, due to an increase in the number of product launches, high demand for acne therapeutics, and an increase in healthcare expenditure, as well as increased awareness of newly developed therapeutics that can replace conventional acne treatment.



Acne Medication Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Acne Medication Market report also contains analysis on:
Acne Medication Market Segments:
By Formulation
Topical
Oral
By Product
Retinoids
Antibiotics
Salicylic Acid
Benzoyl Peroxide
Azelaic Acid
Others
By Type
Prescription
OTC
By Acne Type
Inflammatory Acne
Non-Inflammatory Acne
By Distribution Channel
Retail Stores
Pharmacies & Drug Stores
E-commerce
Acne Medication Market Dynamics
Acne Medication Market Size
Supply & Demand
Current Market Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints


Acne Medication Market Report Scope and Segmentation



Frequently Asked Questions
How big is the Acne Medication market?
What is the Acne Medication market growth?
Which segment accounted for the largest Acne Medication market share?
Who are the key players in the Acne Medication market?
What are the factors driving the Acne Medication market?

ページTOPに戻る

Table of Contents

Contents
1. Executive Summary
2. Acne Medication Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Acne Medication Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Acne Medication Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Acne Medication Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Formulation: Market Share (2020-2030F)
12.2.1. Tropical, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Oral, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Product: Market Share (2020-2030F)
12.3.1. Retinoids, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Antibiotics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Benzoyl Peroxide, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Salicylic Acid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Azelaic Acid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Type: Market Share (2020-2030F)
12.4.1. Prescription, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. OTC, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By Acne Type: Market Share (2020-2030F)
12.5.1. Inflammatory Acne, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Non-Inflammatory Acne, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.6. By Distribution Channel: Market Share (2020-2030F)
12.6.1. Retail Stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.6.2. Pharmacies & Drug Stores, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.6.3. E-commerce, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Allergan Plc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Glaxosmithkline Plc
13.3. Johnson Johnson
13.4. Mayne Pharma Group Limited
13.5. Mylan N V
13.6. Nestle S A
13.7. Pfizer Inc
13.8. Sun Pharma
13.9. Teva Pharmaceutical Industry Ltd
13.10. Valeant Pharmaceutical International
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.